VANCOUVER, British Columbia--Pfizer Animal Health will present data from
discovery studies validating specific pathways of allergic skin disease
in dogs and studies evaluating novel molecules targeting these pathways
at the 7th World Congress of Veterinary Dermatology (WCVD) Meeting 2012
in Vancouver, British Columbia, from July 24–28. Approximately six
presentations related to Pfizer’s research and development program in
veterinary dermatology are scheduled.
“Pfizer Animal Health is committed to advancing research in veterinary
dermatology,” said Candace Sousa, DVM, DABVP, DACVD, a dermatologist and
senior veterinary specialist with the Pfizer Animal Health Veterinary
Specialty Team. “We believe new data presented at WCVD will enable
veterinarians to think about the pathobiology of allergic skin diseases
in different ways. These studies provide evidence that will guide
research into new therapies that target these disease pathways, which
are involved in a number of veterinary dermatological conditions.”
According to Sousa, these new pathways also are described in an
article—“Current Understanding of the Pathophysiologic Mechanisms of
Canine Atopic Dermatitis”—in the July 15 edition of the Journal of the
American Veterinary Medical Association (Marsella R, Sousa C, Gonzales
A, Fadok V. JAVMA. Jul. 15, 2012; 241(2): 194-207).
Sousa said these new data demonstrate Pfizer’s ongoing focus on
veterinary dermatological research to identify new, much-needed
treatment options for allergic skin conditions.
“Good dermatologic health and skin care are critically important pieces
of the overall pet wellness experience; data shows four out of the top
five reasons for seeing a companion animal veterinarian are related to a
dermatologic condition,” Sousa said. “With the presentation of this data
and other company initiatives, Pfizer Animal Health is working to
advance the understanding of dermatology and ultimately give
veterinarians the ability to treat allergic skin conditions in new ways.”
About Pfizer Animal Health
Pfizer Animal Health, a business unit of Pfizer Inc, is a world leader
in the discovery, development and manufacture of innovative animal
health vaccines, medicines, diagnostic products and genetic tests. We
work to assure a safe, sustainable global food supply from healthy beef
and dairy cattle, swine, poultry, sheep and fish while helping dogs,
cats and horses live healthier longer lives. We strive to be the animal
health company that provides full healthcare solutions to veterinarians,
livestock producers, and pet owners. To learn more, visit https://animalhealth.pfizer.com.
For further information, Contact:
Deron Johnson
Pfizer Animal Health
973-660-5567
Deron.Johnson@pfizer.com
or
Emily Dahlbeck
archer>malmo
901-523-2000
edahlbeck@archermalmo.com